August 2012
-
US biopharmaceutical company NanoBio Corporation has changed its name to BlueWillow Biologics, which the company says “reflects its evolution to a vaccines-focused company, and commitment to advancing its novel intranasal technology to develop new vaccines… Read more . . .
-
Janssen Pharmaceutical has announced that data from a Phase 3 study demonstrated significantly significant and clinically meaningful reduction of symptoms in adult patients with treatment-resistant depression who received esketamine nasal spray plus an oral antidepressant… Read more . . .
-
Engage Therapeutics has announced the initiation of the double-blind, randomized Phase 2b StATES (Staccato Alprazolam Terminates Epileptic Seizures) trial of inhaled alprazolam in epilepsy patients who have seizures with a predictable pattern. The company said… Read more . . .
-
Approximately 550 OINDP specialists attended RDD 2018 in Tucson, Arizona, where much of the interest centered around regulatory issues, especially in light of the FDA’s recent release of a revised draft guidance on MDI and… Read more . . .
-
Leading diabetes research funder JDRF has awarded a 2-year $525,000 grant to International Diabetes Center (IDC) to support a study of intranasal insulin in Type 1 diabetes patients with hypoglycemia unawareness, the first time that… Read more . . .
-
Posted on OINDPnews on May 2, 2018. Job postings may or may not be removed from the site after the position is filled. Catalent, Morrisville, NC, USA Position Summary The role supports Catalent’s Inhalation product… Read more . . .
-
Avadel Pharmaceuticals has announced the launch of Noctiva desmopressin nasal spray for the treatment of nocturia due to nocturnal polyuria (overproduction of urine at night) in adults. Avadel acquired US and Canadian rights to Noctiva… Read more . . .
-
Smartinhaler maker Adherium has announced a collaboration with pulmonary disease management provider Vitalus Health for promotion of Adherium’s inhaler monitoring technology to COPD patients in the southwest US. In September 2017, Adherium’s SmartTouch sensor received… Read more . . .
-
Clement Clarke International has announced the availability of a new smartphone app called the Trainhaler Buddy for use with its Trainhaler device to teach patients correct inhaler use technique. The Trainhaler Buddy app uses animations… Read more . . .
-
Submit abstracts for oral and poster presentations by 13 July 2018 at https://aerosol-soc.com/abstract-submission/ Abstract guidelines can be found at https://aerosol-soc.com/assets/uploads/2018/04/DDL-Abstract-Guidelines-2018.doc Themes for DDL2018 are: Insights in respiratory medicine – New therapeutic opportunities for treating asthma,… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland